Phase I Study of Sorafenib, Pemetrexed, and Cisplatin for the Treatment of Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Cisplatin; Pemetrexed; Sorafenib
- Indications Advanced breast cancer; Colon cancer; Head and neck cancer; Lung cancer; Mesothelioma; Pancreatic cancer; Prostate cancer; Sarcoma; Solid tumours
- Focus Adverse reactions
- 05 Jun 2018 Results (n=16) presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 30 Nov 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 30 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.